Freshpet CEO’s August 26 trades show a 9% stake reduction but a low‑price purchase, underscoring a disciplined, plan‑driven strategy amid steady growth and healthy insider confidence.
Medifast insider Kiai Parsa ramps up buying—over 700,000 shares as the stock climbs 28% monthly. Is this a bullish signal or over‑valuation? Click to learn more.
EVP Carlos Linares’s rapid buy‑sell moves on Church & Dwight stock signal confidence in the company’s product pipeline and liquidity strategy, offering investors a nuanced view of insider confidence and market implications.
Colgate‑Palmolive insider sale: COO sells 10k shares at $92.05—routine liquidity, not a red flag. Investor outlook remains positive amid steady buying and selling trends.